Our Team.

Management

Filippa Shub, M.Sc, MBA, Patent and Trade Mark Attorney

COO

An accomplished healthcare industry exec with experience in Operations, IP and Clinical Trials Management, including CSL and Starpharma.

Richard Foitzik, PhD

Director of Medicinal Chemistry

With over 15 years commercial medicinal chemistry experience and an inventor on 15 patents, including IP licensed to Pfzier and Amplia and in clinical development.

Roy Kong, PhD

Principal Scientist

Roy has extensive experience in designing translational programs around preclinical fibrosis models and assays and progressing leads rapidly to the clinic. He was previously Research Director of Molecular Biology with both Certa and OccuRx.

Consultants

Dr Neil Miller

Medchem Consultant

Dr Alan Naylor

Medchem Consultant

Prof Andrew Coats

Clinical Consultant

Board Directors

Founders

A Prof. Siew Chai

Co Founder and IRAP expert

A Prof. Tracey Gaspari

Co-founder and IRAP pharmacology expert

Prof. Phil Thompson

Co-founder and

medicinal chemist

Prof. Rob Widdop

Co-founder and

IRAP physiology expert

David Phillips

Executive Chair

David has over 40 years pharmaceutical industry experience including as a Member of the Exec team at Galapagos, Senior marketing exec with GSK and Managing Partner of GSK’s Corporate Venture Fund.

Emil Bujak, PhD, CFA

Emil is Life Sciences Partner of IP Group. He brings more than 15 years of experience in life sciences investing and research. Emil began his career as a registered pharmacist and holds a PhD and an MSc in Medicinal and Industrial Pharmaceutical Sciences and is also a CFA charterholder.